Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Urban blacks, Hispanics have increased incidence of CLL, DLBCL, respectively

Publish date:: May 27, 2020

Key clinical point: DLBCL incidence was increased among urban Hispanics vs. rural, and increased CLL incidence was seen among urban non-Hispanic Blacks vs. rural.

Major finding: DLBCL incidence among Hispanics was greater in urban areas compared to rural areas (rural IRR = 1.00; metropolitan urban=1.55).

Study details: Comparative review of 136,197 DLBCL, 70,882 FL, and 120,319 CLL cases aged ≥ 20 years.

Disclosures: The study was sponsored by the NIH. The researchers did not report conflict information.

Citation:

Blansky D et al. Clinical Lymphoma, Myeloma and Leukemia. 2020; doi.org/10.1016/j.clml.2020.05.010.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in DLBCL

Synthetic lethality: Triple combination is a viable strategy for B-cell malignancies,

Bispecific antibody odronextamab demonstrates durable complete responses in refractory NHL,

Survey quantifies COVID-19’s impact on oncology,

Sarcopenia is a predictor of overall survival in DLBCL patients,

Mutation tied to central nervous system collapse in DLBCL,